Axial Biotherapeutics raised $37.3M Series C venture round, led by Sarah Meibusch.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — |
OneVenturesLEAD | Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$91.4M
Top Valuation
-
Axial Biotherapeutics raised $37.3M in a Series C round.
The round was announced on 10/13/21.
The round was led by Sarah Meibusch, Makoto Ohori.